Table 3 Treatment patterns for treatment of flares occurring at any time during the study period
From: Gout treatment and comorbidities: a retrospective cohort study in a large US managed care population
Gout drugs within 7 days of flare | ||
|---|---|---|
(any flare) n = 32,244 | ||
n | % | |
NSAIDS | 21,633 | 67.1% |
selective | 1,283 | 4.0% |
nonselective | 20,748 | 64.3% |
Colchicine | 12,847 | 39.8% |
Corticosteroids | 8,598 | 26.7% |
Probenecid | 420 | 1.3% |
Allopurinol | 9,644 | 29.9% |
No treatment | 0 | 0.0% |